(Q45155184)

10 December 2017

Gender differences in clinical presentation and response to sertraline treatment of generalized anxiety disorder (English)

1 reference

10 December 2017

1 reference

1

1 reference

10 December 2017

Christer Allgulander

2

1 reference

10 December 2017

Arun Ravindran

3

1 reference

10 December 2017

Hana Kosar

4

1 reference

10 December 2017

Tal Burt

5

1 reference

10 December 2017

Carol Austin

6

1 reference

10 December 2017

1 January 2005

1 reference

10 December 2017

Human Psychopharmacology

1 reference

10 December 2017

20

1 reference

10 December 2017

3-13

1 reference

10 December 2017

1

1 reference

Psychiatric comorbidity in patients with generalized anxiety disorder.

10 December 2017

1 reference

The assessment of anxiety states by rating

21 January 2018

1 reference

The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Phobia, generalized anxiety disorder, panic disorder, bulimia, major depression, and alcoholism

21 January 2018

1 reference

Past-year use of outpatient services for psychiatric problems in the National Comorbidity Survey.

21 January 2018

1 reference

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam

21 January 2018

1 reference

DSM-III-R generalized anxiety disorder in the National Comorbidity Survey.

21 January 2018

1 reference

Is the course of panic disorder the same in women and men?

21 January 2018

1 reference

Efficacy of sertraline in a 12-week trial for generalized anxiety disorder

21 January 2018

1 reference

7 January 2021

Venlafaxine extended release (ER) in the treatment of generalised anxiety disorder: twenty-four-week placebo-controlled dose-ranging study

1 reference

7 January 2021

High prevalence of mental disorders in primary care

1 reference

7 January 2021

Comorbidity among anxiety disorders: implications for treatment and DSM-IV.

1 reference

7 January 2021

One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample

1 reference

7 January 2021

Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder

1 reference

7 January 2021

Sex differences in allelic frequencies of the 5-HT2C Cys23Ser polymorphism in psychiatric patients and healthy volunteers: findings from an association study

1 reference

7 January 2021

Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.

1 reference

7 January 2021

Psychic and somatic anxiety: worries, somatic symptoms and physiological changes

1 reference

7 January 2021

Generalized anxiety disorder in women

1 reference

7 January 2021

DSM-IV generalized anxiety disorder in the Australian National Survey of Mental Health and Well-Being.

1 reference

7 January 2021

Comorbidity as a fundamental feature of generalized anxiety disorders: results from the National Comorbidity Study (NCS).

1 reference

7 January 2021

Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials

1 reference

7 January 2021

Pharmacogenetics of antidepressant and mood-stabilizing drugs: a review of candidate-gene studies and future research directions

1 reference

7 January 2021

Gender differences in anxiety disorders and anxiety symptoms in adolescents.

1 reference

7 January 2021

Quality of life and psychiatric morbidity in panic disorder and generalized anxiety disorder

1 reference

7 January 2021

A New Depression Scale Designed to be Sensitive to Change

1 reference

7 January 2021

Characterization of the longitudinal course of improvement in generalized anxiety disorder during long-term treatment with venlafaxine XR.

1 reference

7 January 2021

Generalized anxiety disorder vs. panic disorder. Distinguishing characteristics and patterns of comorbidity

1 reference

7 January 2021

Common mental disorders and disability across cultures. Results from the WHO Collaborative Study on Psychological Problems in General Health Care.

1 reference

7 January 2021

Evaluation of buspirone as an antianxiety agent: buspirone and diazepam versus placebo

1 reference

7 January 2021

Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial

1 reference

7 January 2021

Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome

1 reference

7 January 2021

Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder.

1 reference

7 January 2021

Gepirone and diazepam in generalized anxiety disorder: a placebo-controlled trial

1 reference

7 January 2021

Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study.

1 reference

7 January 2021

Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers.

1 reference

7 January 2021

Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder

1 reference

7 January 2021

Pharmacogenetics in affective disorders

1 reference

7 January 2021

Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey.

1 reference

7 January 2021

Factors predicting the clinical course of generalised anxiety disorder.

1 reference

7 January 2021

Phenomenology and course of generalised anxiety disorder.

1 reference

7 January 2021

The hospital anxiety and depression scale

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.648

1 reference

10 December 2017

1 reference